Metabolomics of cerebrospinal fluid reveals candidate diagnostic biomarkers to distinguish between spinal muscular atrophy type II and type III

CONCLUSION: This study identified metabolic markers are promising candidate prognostic factors for SMA. We also identified the metabolic pathways associated with the severity of SMA. These assessments can help predict the outcomes of screening SMA classification biomarkers.PMID:38615366 | PMC:PMC11016346 | DOI:10.1111/cns.14718
Source: CNS Neuroscience and Therapeutics - Category: Neuroscience Authors: Source Type: research